Mosapride Citrate Dihydrate: A Selective 5-HT4 Agonist for Gastrointestinal Motility Disorders

Enhancing digestive health through targeted gastrointestinal motility support.

Get a Quote & Sample

Key Advantages

Targeted Motility Enhancement

Mosapride Citrate Dihydrate selectively stimulates 5-HT4 receptors, leading to increased acetylcholine release and improved gastrointestinal motility, a crucial aspect when considering digestive system therapeutics.

Alleviation of Dyspepsia Symptoms

It offers significant relief from symptoms associated with functional dyspepsia, contributing to better patient comfort and quality of life by addressing common complaints like bloating and early satiety.

Favorable Selectivity Profile

With minimal impact on 5-HT3 receptors, it reduces the risk of certain side effects often associated with non-selective agents, making it a preferred choice for managing gastrointestinal motility disorders.

Key Applications

Gastroesophageal Reflux Disease (GERD)

This agent is instrumental in managing GERD by accelerating gastric emptying, a critical step in the treatment of GERD and reducing acid reflux.

Functional Dyspepsia Management

Its prokinetic properties make it highly effective for the treatment of functional dyspepsia, improving overall digestive comfort.

Chronic Gastritis Support

Mosapride Citrate Dihydrate can be used to support patients with chronic gastritis by improving gastric motility and reducing associated symptoms.

Pharmaceutical Intermediate Use

As a key API, it serves as a crucial intermediate in the formulation of various pharmaceutical products aimed at enhancing gastrointestinal motility.